138 related articles for article (PubMed ID: 380437)
1. Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.
Weiss RB; DeVita VT
Ann Intern Med; 1979 Aug; 91(2):251-60. PubMed ID: 380437
[TBL] [Abstract][Full Text] [Related]
2. Postsurgical adjuvant chemotherapy: a review.
Diekamp U; Lad TE; McGuire WP
Surg Annu; 1981; 13():31-52. PubMed ID: 7025285
[No Abstract] [Full Text] [Related]
3. [Possibilities and perspectives of adjuvant chemotherapy in malignant tumors].
Tanneberger S
Vopr Onkol; 1989; 35(8):899-904. PubMed ID: 2800442
[No Abstract] [Full Text] [Related]
4. Current trends and prospects in surgical adjuvant trials.
Rozencweig M; von Hoff DD; Louie AC; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):673-9. PubMed ID: 282827
[TBL] [Abstract][Full Text] [Related]
5. Effective adjuvant treatments. A brief review of U.S. clinical trials.
Louie AC; Rozencweig M; von Hoff DD; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):653-8. PubMed ID: 282826
[TBL] [Abstract][Full Text] [Related]
6. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
7. Experimental adjuvant chemotherapy: an overview.
Skipper HE
Recent Results Cancer Res; 1986; 103():6-29. PubMed ID: 3738196
[No Abstract] [Full Text] [Related]
8. Rationale for adjuvant chemotherapy.
Schabel FM
Cancer; 1977 Jun; 39(6 Suppl):2875-82. PubMed ID: 141322
[No Abstract] [Full Text] [Related]
9. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
Wynendaele W; van Oosterom AT
Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy in prevention of the recurrence of resectable cancer.
Bonadonna G; Tancini G; Rossi A; Gasparini M
Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
[No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy for common solid tumors.
Berstock DA; Baum M
Adv Cancer Res; 1983; 39():315-27. PubMed ID: 6353886
[No Abstract] [Full Text] [Related]
12. Chemoimmunotherapy of human solid tumors.
Gutterman JU; Mavligit GM; Hersh EM
Med Clin North Am; 1976 May; 60(3):441-62. PubMed ID: 1063907
[No Abstract] [Full Text] [Related]
13. [Intra- or Postoperative Chemoprophylaxis? (author's transl)].
Senn HJ
Langenbecks Arch Chir; 1975 Nov; 339():85-93. PubMed ID: 813077
[TBL] [Abstract][Full Text] [Related]
14. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber F; Giuliano A; Eckardt J; Patterson K; Moseley S; Goodnight J
J Clin Oncol; 1987 Jan; 5(1):21-6. PubMed ID: 3543236
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?
Carter SK
J Clin Oncol; 1984 Mar; 2(3):147-8. PubMed ID: 6583329
[No Abstract] [Full Text] [Related]
17. Optimal timing of adjuvant chemotherapy in mouse models.
van Putten LM
Prog Clin Biol Res; 1985; 201():15-21. PubMed ID: 3867900
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
[TBL] [Abstract][Full Text] [Related]
19. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
20. Update on the role of adjuvant interferon for high risk melanoma.
Agarwala SS; Kirkwood JM
Forum (Genova); 2000; 10(3):230-9. PubMed ID: 11007931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
